This study is in progress, not accepting new patients
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Antoni Ribas
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Antoni Ribas
Professor, Medicine. Authored (or co-authored) 433 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT01351103
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- About 185 people participating
- Last Updated